Table 1 Baseline characteristics and specific pathological features of patients with ATAAD.
From: Aggrecan: a new biomarker for acute type A aortic dissection
Characteristics (n = 33) | n (%) |
|---|---|
Age, mean (SD), years | 65 ± 12.1 |
Sex | |
Male | 15 (45.5) |
Female | 18 (54.5) |
Left ventricular ejection fraction | |
Normal | 31 (94) |
Slightly reduced | 2 (6) |
Moderately reduced | 0 |
Severely reduced | 0 |
Coronary artery disease | 6 (18) |
Peripheral arterial disease | 1 (3) |
Carotid artery disease | 1 (3) |
Cardiovascular risk factors | |
Arterial hypertension | 27 (82) |
Hyperlipidemia | 10 (30) |
Diabetes mellitus | 5 (15) |
Obesity | 5 (15) |
Nicotine abuse | 12 (36) |
Family disposition | 5 (15) |
COPD | 1 (3) |
Chronic kidney disease | 1 (3) |
Prior stroke | 3 (9) |
Prior myocardial infarction | 1 (3) |
Osteoarthritis | 0 |
Prior cardiac surgery | 1 (3) |
Stanford classification | |
Type A | 33 (100) |
Type B | 0 |
DeBakey classification | |
Type I | 20 (60.6) |
Type II | 13 (39.4) |
Type III | 0 |
Preoperative false lumen status | |
Patent | 33 (100) |
Partially thrombosed | 0 |
Totally thrombosed | 0 |
Preoperative lower extremity ischemia | 1 (3) |
Prior thoracic aortic aneurysm | 20 (60.4) |
Mean aortic aneurysm size (SD) | 40.8 mm ± 23.5 |
Aortic valve disease | 16 (48.5) |
Aortic stenosis | 0 |
Aortic regurgitation | 16 (48.5) |
AR I° | 7 |
AR II° | 6 |
AR III° | 3 |
Bicuspid aortic valve | 1 (3) |
Underlying syndrome | |
Marfan | 2 (6) |
Ehlers Danlos | 0 |
Loeys-Dietz | 0 |
Turner | 0 |
Iatrogenic aortic dissection | 1 (3) |
